Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Wild

Showing results (131-140 of 134) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 134 results.
Biology of Reproduction|November 9, 2007
Adaptive responses by mouse early embryos to maternal diet protect fetal growth but predispose to adult onset diseaseAdam J Watkins, Elizabeth Ursell, Rose Panton, et al.
Gut|April 11, 2006
Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trialG Van Assche, W J Sandborn, B G Feagan, et al.
Plos One|September 29, 2009
Genetic variation in the familial Mediterranean fever gene (MEFV) and risk for Crohn's disease and ulcerative colitisAlexandra-Chloé Villani, Mathieu Lemire, Edouard Louis, et al.
The American Journal of Gastroenterology|May 16, 2006
Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohortGeoffrey C Nguyen, Esther A Torres, Miguel Regueiro, et al.
Pageof 14

Showing results (131-140 of 134) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 134 results.
Biology of Reproduction|November 9, 2007
Adaptive responses by mouse early embryos to maternal diet protect fetal growth but predispose to adult onset diseaseAdam J Watkins, Elizabeth Ursell, Rose Panton, et al.
Gut|April 11, 2006
Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trialG Van Assche, W J Sandborn, B G Feagan, et al.
Plos One|September 29, 2009
Genetic variation in the familial Mediterranean fever gene (MEFV) and risk for Crohn's disease and ulcerative colitisAlexandra-Chloé Villani, Mathieu Lemire, Edouard Louis, et al.
The American Journal of Gastroenterology|May 16, 2006
Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohortGeoffrey C Nguyen, Esther A Torres, Miguel Regueiro, et al.
Pageof 14